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African sleeping sickness is caused by Trypanosoma brucei gambiense and T. 
b.  rhodesiense.  This disease resulted in the deaths of several million people 
during the first half of the twentieth century (1) and continues to pose a threat of 
new epidemics (2). Of even more significance is the fact that animal trypanoso- 
miasis or nagana (T. congolense, T. b. brucei, and T. vivax) makes four million 
square miles of the African continent unsuitable for the production of cattle and 
other livestock (3). The first trypanocidal agents were developed by Ehrlich and 
his collaborators in the early part of this century. Over the next 50 yr, drugs 
such  as  tryparsarnide,  suramin,  pentamidine,  berenil,  ethidium,  Antrycide, 
and melarsoprol became available  for use in  the treatment of both  sleeping 
sickness  and  nagana  (4).  For the  past  20  yr,  however,  there have  been no 
new chemotherapeutic agents introduced. Moreover, the therapeutic usefulness 
of the older drugs is diminishing due to the increased incidence of resistant 
strains (5). 
We  have  been  attempting  to  develop  new  chemotherapeutic  agents  by 
elucidating biochemical differences between trypanosomes and their hosts and 
then  designing  drugs  to  take  advantage  of these  differences.  The  present 
communication describes such an approach to drug development. The biochem- 
ical difference we have exploited is the inability of T.  b.  brucei to synthesize 
heine (6). As a result of this deficiency and the avid binding of heine to serum 
proteins in mammalian hosts,  the bloodstream form of this organism has no 
detectable heine (S.  R.  Meshnick and S. Sassa,  unpublished results) or hemo- 
proteins such as cytochromes (7) or catalase (8). In a  previous communication 
(9) we reported that the lack ofcatalase in T. b. brucei leads to an accumulation 
of intracellular  hydrogen peroxide  (H202)  in  these organisms,  which should 
increase their susceptibility to  killing by agents that promote the homolytic 
cleavage  of H202  yielding hydrexy  (HO.)  or  hydroperoxy (HOO.)  radicals. 
Presumably, these radicals would react with unsaturated lipids and other cell 
constituents, thereby leading to cell destruction. Heme proved to be trypanocidal 
in  vitro,  whereas  several  other porphyrins  showed in  vivo  activity  (9).  We 
ascribed this to their acting as initiators of homolytic cleavage. To enhance the 
efficacy of this therapeutic approach, we have attempted to determine the site 
of H202 production, the fate of the H202 generated, a means of increasing H202 
production,  and  lastly,  ways of rendering trypanosomes more susceptible  to 
radical damage. 
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Materials and Methods 
Chemicals.  Heroin (type I, bovine), DL-alanine, DL-~-glycero1  phosphate (DL-~GP),  ~  glutathi- 
one (GSH), menadione, hematoporphyrin, D-amino acid oxidase (0.2 U/rag), and catalase (30,000 
U/rag)  were  obtained from  the  Sigma Chemical Co.,  St.  Louis,  Mo.  Salicylhydrexamic acid 
(SHAM) and 2-methoxy-naphthoquinone  was purchased from the Aldrich Chemical Co.,  Inc., 
Milwaukee,  Wis.  Both  dichlorephenolindophenol (DCIP)  and  leucediacetyldichlorofluorescin 
(LDADCF) were products of the Eastman Organic Chemicals Div. Eastman Kodak Co., Rochester, 
N.Y.  Tryparsamide was purchased from K  and K  (Plainview, N.  Y.),  whereas melarsen and 
melarsenoxide were gifts from Dr. E. A. Friedheim of The Rockefeller University. 
Horseradish  peroxidase  (880 U/rag)  was  obtained from  Worthington Biochemical  Corp., 
Freehold, N. J.  Bovine serum albumin and minimal essential medium (MEM) were purchased 
from Miles Laboratories Inc., Elkhardt, Ind., and Grand Island Biological Co., Grand Island, N. 
Y.,  respectively.  Hematoporphyrin D was  prepared  from  hematoporphyrin by the method of 
Lipson et al. (11). Vitamin K-S(II) was a gift from Dr. C. C. Wang of Merck & Co., Inc., Rahway, 
N.J. 
Animals.  BALB/c and Swiss-Webster mice were obtained from the Charles River Breeding 
Laboratories, Inc., Wilmington, Mass., and The Rockefeller  University, respectively. Sprague- 
Dawley rats were purchased from the Holtzman Co., Madison, Wis). Dutch-belted rabbits were 
from Dutchland, Denver, Pa. 
Organisms.  T.b.  brucei  (EATRO 110) were obtained from Dr.  W. Trager (The Rockefeller 
University) and stored as stabilates in 10% glycerol  at -80°C. This strain had been paseaged 
seven times in rodents since it was last transmitted by tsetse flies. Intraperitoneal il~jection of 2 
× 104 motile organisms into Swiss-Webster mice (20-g males) yielded pleomorphic infections  with 
slender forms predominating  5-7 days after infection. 
A monomorphic strain, EATRO 110 M, was derived from EATRO 110 via serial passages (>100) 
in mice. These organisms were uniformly slender in morphology. They were routinely harvested 
from Swiss-Webster mice or Sprague-Dawley rats (250-350-g females) 3-4 days after infection. 
Isolation of Trypanosomes.  Trypanosomes were isolated from blood according to the procedure 
of Lanham and Godfrey (11). Infected mice were bled retro-orbitally with heparinized pipettes, 
whereas infected rats were lightly etherized and then bled by cardiac puncture into heparinised 
syringes. Whole blood (10 ml) was applied to a column (2.5 × 7 cm) of Whatman DE-52 cellulose 
and eluted with phosphate-buffered saline and glucose (PSG 6:4). For preparation of mitochondrial 
fractions, whole blood was first centrifuged for 20 rain at 2,000 g in a Sorvall RC 2B refrigerated 
centrifuge (DuPont Instrumente-Sorvall, DuPont Co.,  Wilmington, Del.).  The resulting huffy 
coat was gently removed and eluted from a column as described above. A column with a packed 
volume of 50 ml could then be used for the equivalent of 50 ml of blood. 
Preparation  of Mitochondria.  Isolated bloodstream forms of T.  b.  brucei  (EATRO  110 M) 
obtained from rats were washed three times in PSG 6:4. The organisms (1 x  101°) were pelleted 
and resuspended in 40 ml of distilled water. After I rain, lysis was stepped by the addition of 10 ml 
of 1 M mannitol and 1 ml of 1 M potassium phosphate buffer (pH 7.5). Approximately 90~ of the 
organisms was found to be lysed.  The lysate was centrifuged at 1,000 g  for  10 rain, and the 
supernate was stored on ice. The resulting pellet was resuspended in 10 ml of 20 mM potassium 
phosphate buffer containing  0.25 M mannitol (pH 7.5), and then homogenized  (6-10 strokes) with 
an Eberbach homogenizer (Eberbach Corp., Ann Arbor, Mich.). The homogenate was centrifuged 
as above.  The supernates were combined and centrifuged at 20,000 g for 20 rain. The resulting 
pellet was resuspended in the above buffer and utilized for assays. 
Measurement of  Hydrogen Peroxide.  Hydrogen peroxide was assayed as described by Homan- 
Muller and Roos (12). A stock solution of 4 /~M of activated LDADCF was prepared in 0.025 M 
sodium phosphate buffer (pH 7.2) containing 4% ethanol and 5 ~g/ml of horseradish peroxidase. 
To 3 ml of the stock solution  was added 0.2 ml of sample, after which the solution  was incubated at 
1Abbreviations  used  in this paper:  CoQ, ceenzyme Q; DCIP,  dichlorophenolindophenol; DL- 
aGP,  DL-a-glycerol phosphate;  DMF,  dimethyl formamide; DMSO,  dimethyl sulfoxide;  GSH, 
glutathione; GSSG, oxidized glutathione; LDADCF, leucodiacetyldichlorofluorescin;  MEM, mini- 
mal essential medium; PSG, phosphate-buffered saline and glucose; SHAM,  salicylhydroxamic 
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room temperature  for 20  rain.  Fluorescence was measured  with  a  Perkin-Elmer spectrofluo- 
rometer (model 204; Perkin Elmer Corp., Norwalk, Conn.) employing an excitation wavelength 
of 340 nm, and observing the emission at 520 nm. A standard curve was determined for freshly 
diluted  hydrogen peroxide solutions  utilizing  an extinction  coefficient  v-f  E  c~3o = 81. The assay 
was found to be linear  from 10  -7 to 10-  5 M  hydrogen peroxide. 
The hydrogen  peroxide  content ofT. b. brucei (EATRO 110  M) was  determined  in  the  following 
manner. Isolated  organisms (10  TM)  were washed three  times  in PSG 6:4  and then  homogenized for 
25 s in 10 ml of distilled  water using a Virtis homogenizer (model S-45).  Aliquots of the 
homogenate were  assayed  for  their  H202  content as  described  above.  The  background  fluorescence 
of  the homogenate was determined by adding  5 ~g of  catalaso  to  0.2  ml of  the homogenate 5 min 
before  incubation with LDADCF.  Catalase did not quench the fluorescence  in  this  assay system. 
The aGP-dependent rate  of production of hydrogen  peroxide by mitochondrial preparations 
was determined at 23°C by the following  procedure. The assay mixture contained enzyme 
substrate and activated LDADCF  (2 ~tM) in 50 mM  potassium phosphate buffer (pH 7.5) 
containing 2% ethanol and 5 ~tg/ml  of  horseradish peroxidase.  The relative  fluorescence  of  the 
assay  mixture  was recorded  as  a function  of  time.  Calibration  of  the  rate  of  change  of  fluorescence 
was achieved by adding varying amounts of  D-amino acid oxidase to assay solutions  containing 
3.3  mM  DL-alanine.  The activity  of  the  D-amino  acid  oxidase in  these  solutions  was determined  by 
measuring  the oxygen  consumption of  an aliquot  in  the  presence of  3.3  mM  vL-alanine. 
Assays for Glycerol Phosphate Oxidase and Dehydrogenase.  Glycerol phosphate dehydrogen- 
ase activity was measured using DCIP as the electron accepter (13). Glycerol phosphate oxidase 
activity was determined by following oxygen consumption  in the  presence of DL-aGP with  a 
Clark-type, oxygen electrode (Rank Brothers, Cambridge, England). 
Determination of Peroxidase Activity.  Assays for endogenous peroxidase activity were per- 
formed  as  follows.  Homogenates  of T.  b.  brucei  (EATRO  110  M)  were  prepared  in  50  mM 
potassium phosphate buffer (pH 7.5). Aliquots of homogenate (1.5 mg) were incubated at 24°C in 
3 ml of 50 mM potassium phosphate buffer (pH 7.5) containing activated LDADCF (2 ~M)  and 
H202 (0.3 ~M), with either DL-aGP (0.4 mM) or GSH (0.04 mM). After 10 min, 15 ~g of horseradish 
peroxidase was added.  After an additional 20-min incubation, H202 was quantitated fluorometri- 
cally as described above.  The fluorescence measured in the absence of H202 has been subtracted 
from all measurements. 
Miscellaneous Biochemical Assays.  Reduced and oxidized GSH was determined by the method 
of  Tietze  (14). Coenzyme  Q  (CoQ) was  assayed  by  the  method  of  Redfearn  (15). Protein 
concentrations were determined by the method of Lowry et al.  (16) using bovine serum albumin 
as a standard. 
Assessment of Trypanocidal Activity in Vitro.  The trypanocidal activity of various compounds 
was assessed in vitro by following their effect on the turbidity of suspensions of trypanosomes. T. 
b.  brucei  (EATRO 110 M) were suspended in PSG 6:4/MEM 9/1 at a concentration of 1-2  ×  l0  T 
organisms/ml,  and  they  were  maintained  at  37°C. The  turbidity  of such  a  suspension  was 
measured  at 750  nm in a  1-ml  cuvette with a  Beckman Acta III recording spectrophotometer 
(Beckman Instruments, Inc., Cedar Grove, N.J.). Heme in dimethyl formamide (DMF), naphtho- 
quinones  in  dimethyl sulfoxide  (DMSO)  and/or arsenicals  in  DMSO  were  added  to  the  final 
concentrations indicated. In no case was the volume of DMF or DMSO added greater than 10 ~1/ 
ml of suspension. These small amounts of organic solvents had no effect on the turbidity of the 
suspensions or the motility of the organisms. Where lysis was indicated by a decrease in turbidity, 
it was confirmed by inspection of the suspension by phase contrast microscopy. 
Assessment of Trypanocidal Activity in  Vivo.  Groups of five BALB/c mice (20-25-g males) 
were infected with T. b. brucei (5 × 104 organisms). 24 h after infection, the animals were treated 
with single doses  of tryparsamide,  hematoporphyrin D,  or a combination of both drugs at the 
concentrations indicated. The drugs were administered i.p.  as suspensions in 0.25% methylcellu- 
lose. In calculating average survival times, we considered those mice alive at 28 days to be cured. 
Results 
Fig.  1 is a  working model of the relevant biochemistry and shows the points 
at  which  we  have  attempted  to  intervene.  As  a  consequence  of its  lacking 
cytochromes, the bloodstream form of T.  b.  brucei  has an unusual  metabolism; 572  NEW  DRUGS FOR  AFRICAN  TRYPANOSOMIASIS 
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FIG.  1.  A proposed scheme for electron transport in bloodstream forms of T.  b.  brucei. 
DHAP, dihydroxyacetone phosphate; GPDH,  a-glycerol phosphate dehydrogenase. 
namely, aerobic glycolysis. It is estimated that the organism consumes its dry 
weight in  glucose every 90  min  (17). Glucose is metabolized only as  far as 
pyruvate (20); the NAD reduced during glycolysis is regenerated in microbodies 
by the reduction of dihydroxyacetone  phosphate (19, 20). The aGP formed is in 
turn recycled by an oxidase complex which is associated with a  rudimentary 
mitochondria (21). 
Most of the electrons from the oxidation of aGP are incorporated into water. 
Mitochondrial preparations, in the presence of 7 mM DL-aGP at 23°C, consumed 
21-29 nmoles of OJmin/mg of protein, but produced only 0.2-0.7 nmoles of H202/ 
min/mg of protein. Thus, ~ 1-3% of the oxygen consumed forms H202. A similar 
partitioning of 02 to form H20 and H202 has been reported in mitochondrial 
preparations from rat liver (22) and Crithidia fasciculata  (23). 
The mitochondrial oxidase is a complex of at least two components, an aGP 
dehydrogenase and a terminal oxidase (21). The activity of the dehydrogenase 
can be measured using artificial electron acceptors such as DCIP, and it is not 
inhibited by either Triton X-100 or benzhydroxamic acids such as SHAM.  The 
terminal oxidase, on the other hand, is inhibited by both Triton X and SHAM. 
The fact that the production of H202 by the mitochondrial preparation is not 
inhibited by Triton X  (Table I) suggests that the dehydrogenase and not the 
oxidase  is  the  source  of hydrogen peroxide.  However,  since  mitochondrial 
preparations contain  microbodies  (21), we cannot  say with  certainty which 
dehydrogenase is the source of H202. 
The rate of H20~ production described above for the trypanosome is similar to 
that measured in mammalian mitochondria. Thus, the increased concentration 
of H202 in trypanosomes must reflect an inability to degrade this compound. 
While  the  absence  of heme  in  these  organisms  precluded the  presence  of 
catalase, other peroxidases might have been present. Accordingly, trypanoso- 
mal homogenates were assayed for poroxidase activity using a sensitive fluoro- 
metric  technique  (Table  II).  No  decrease  in  H202 concentration  could  be 
observed after incubating for 10 min with an aliquot of trypanosomal homoge- 
nate (experiment 2). Similarly, no decrease in H2O  2 concentration was observed 
when GSH was added to the homogenate (experiment 3). Thus, GSH peroxidase MESHNICK,  BLOBSTICIN, GRADY,  AND  CERAMI 
TABLE  I 
The Effects of Triton X and SHAM on Various Activities of Glycerol Phosphate 
Oxidase Preparations 
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Exp. 
Initial Rates* 
(nmoles/min/mg protein) 
Triton X  SHAM 
0.05%  (1 mM) 
-  +  --  + 
1.  O2 Consumption*  15.7  0.0  15.7  0.0 
2.  DCIP Reduction  28.8  69.0  26.9§  23.1 
3.  H202 Production  0.21  0.22  N.D.II  N.D.¶ 
4.  Menadione-supported 02 consumption*, **  268.0**  393.0  258.0*~  225.0 
5.  Menadione-supported DCIP reduction§  159.0§§  266.0  N.D.  N.D. 
* Initial  rates  were  determined  in  the  presence  of 10  mM  VL-aGP utilizing mitochondrial 
preparations. 
* Oxygen consumption  was  measured  as  described in Fig. 2. 
§ In this experiment a trypanosomal homogenate was utilized. 
II N.D., not determined. 
¶ SHAM inhibits horseradish peroxidase. 
** Initial rates determined in the presence of 0.15 mM menadione. 
** Initial rate in the absence of menadione 44.2 nmoles/min/mg protein. 
§§ Initial rate in the absence of menadione 28.8 nmoles/min/mg protein. 
is not likely to be present.  Furthermore,  no diminution in H202 concentration 
was observed when  aGP was added to the  homogenate  (experiment  4).  This 
latter  experiment  ruled  out  the  possibility  that  H202 was  an  obligatory 
intermediate  in the transfer of electrons from oxygen to water by the glycerol 
phosphate oxidase  (24).  Thus it appears that,  lacking an enzymatic means of 
destroying H202, the organism must depend upon diffusion of this potentially 
lethal metabolite from the cell to its surroundings where it can be disposed of by 
mammalian enzymes. 
It is apparent from Fig. I that increasing the rate of H~O2 production in T. b. 
brucei should increase the size of the intracellular H202 pool and thus make the 
organisms more susceptible to radical generators. We have been able to induce 
increased  H202  production  in  vitro  with  a  number  of naphthoquinones.  As 
shown  in  Fig.  2,  the  addition  of menadione  to  a  trypanosomal  homogenate 
caused a  threefold increase in the rate of oxygen consumption. The addition of 
catalase reduced the apparent rate of 02 consumption by 30-40%, implying that 
60-80% of the oxygen was being converted to H202. Thus, the naphthoquinone 
stimulated H202 production 200- to 300-fold over the normal state. Presumably, 
menadione was enzymatically reduced to the quinol which then reacted nonen- 
zymatically with oxygen to form H202.  Cycling of the naphthoquinone  would 
explain  its catalytic effect on the  production  of H202. Although  we have  not 
been able to definitively identify the site at which menadione interacts,  we do 
not believe it  is  at  the  terminal  oxidase  since  Triton  X,  which  inhibits  the 
oxidase,  did  not  interfere  with  production  of H202 in  the  presence  of the 
naphthoquinone  (Table  I).  The  increased  rate  of reduction  of DCIP  in  the 
presence of menadione, DL-aGP, and Triton X suggests that the naphthoquinone 
is reduced by the dehydrogenase. Since we find substantial amounts of CoQ (0.3 574  NEW  DRUGS  FOR  AFRICAN  TRYPANOSOMIASIS 
TABLE  II 
The Effect of Trypanosomal  Homogenates on H202 in the Presence Of DL 
aGP and GSH 
Exp.  H202 prein-  Trypanoso-  Reduced  H~O2 postin- 
mal  homoge-  DL-aGP 
cubation  GSH  cubation 
nate 
0.3 ~  1.5 mg  0.4 mM  0.04 mM 
1  +  -  -  -  0.30 
2  +  +  -  -  0.29 
3  +  +  -  +  0.26 
4  +  +  +  -  0.25 
nmoles/mg  of protein)  in the  mitochondria  of these  organisms,  we postulate 
that the naphthoquinone  is substituting for CoQ as the electron acceptor of the 
dehydrogenase present in the glycerol phosphate oxidase complex. 
The excess production of H202 caused by a naphthoquinone can be trypanoci- 
dal in vitro.  The lowest concentrations of 2-methoxynaphthoquinone,  menadi- 
one,  and  vitamin  K-S(II) required  to lyse trypanosemes  are  0.3,  0.2,  and  1.8 
mM,  respectively.  As anticipated,  naphthoquinones  and  heme  act synergisti- 
cally in vitro  (Fig.  3). Although the addition of neither 60/~M menadione nor 
3.5  /~M heme had any lytic effect upon trypanosomes  (Fig.  3,  a  and b), when 
administered together,  the two caused a rapid lysis of the organisms  (Fig. 3, a 
and  c).  Under  these  conditions,  the  rate  of killing  was  equivalent  to  that 
observed in the presence of 20/~M heme alone (data not shown). The synergism 
was most evident when the naphthoquinone  was added before heme, implying 
that  an increased pool of intracellular  H202  enhances the susceptibility of the 
organisms to heme lysis. Note that larger amounts of both menadione and heme 
were required to produce lysis when the naphthoquinone was added subsequent 
to heme (Fig.  3 b and c).  Although naphthoquinones  are trypanocidal in vitro 
beth alone and in combination with heme, we have yet to find a naphthoquinone 
which is active in vivo either by itself or in combination with various porphy- 
rins. 
Another  method  of rendering  trypanosomes  more  susceptible  to  radicals 
generated  by heme-induced  decomposition of H202 would be to  decrease  the 
level of intracellular  radical  scavengers.  It  has  been suggested  that  reduced 
GSH  plays  such  a  protective  role  (25).  Hence,  if the  GSH  content  of the 
trypanosomes  were  lowered,  the  organisms  might  be  more  susceptible  to 
radical-mediated damage and killing.  Accumulated evidence suggests that the 
trypanocidal arsenicals in their trivalent oxidation state react with thiols (26). 
Accordingly,  the  effect  of arsenicals  on  intracellular  GSH  was  studied  by 
incubating isolated bloodstream forms of T. b. brucei  (1.3  ×  109 organisms/ml) 
at 23°C with 100-/~M concentrations of either Melarsenoxide or Melarsen in PSG 
6:4.  After  20  min,  the  organisms  treated  with  melarsenoxide,  a  trivalent 
arsenical,  were immobilized but not lysed. Melarsen,  a  pentavalent arsenical, 
had  no  observable  effect on  the  trypanosomes.  The  organisms  were  freeze- 
thawed three  times,  and  the  intracellular  GSH content was determined  (14). 
Melarsenoxide-treated trypanosomes were found to contain 67% less GSH (0.31 
~g/109  cells) than either untreated  trypanosomes (0.92  /~g/109 cells), or Melar- MESHNICK,  BLOBSTEIN,  GRADY,  AND  CERAMI 
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FIG.  2.  The effect of menadione on the oxygen consumption oftzTpanosoma] homogenates. 
An aliquot (100/~]) of homogenized bloodstream  forms of T. b. brucei containing 1 mg of 
protein was added to 1.9 ml of sodium phosphate buffer (100 raM, pH 8.0) containing sodium 
chloride (73 raM). Oxygen consumption was measured in a Clark-type electrode at 37°C. At 
the indicated times, the following were added to obtain the final concentrations listed: DL- 
aGP (10 raM); menadione (0.15 raM); catalase (2,000 U/ml); SHAM (1 raM). The numbers 
shown next to the tracing are the slopes of each segment of the tracing in nmoles of oxygen 
consumed  per  min. 
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sen-treated trypanosomes  (0.85 /~g/l(P  cells). Melarsenoxide  is not simply 
causing the accumulation of oxidized glutathione (GSSG),  since only trace 
amounts  of GSSG  (0.015 /zg/l(P  cells)  were detectable (14). The fact that 
Melarsen does not cause a change in the concentration of GSH  is consistent 
with  the concept that  in  situ  reduction  of  pentavalent arsenicals  to  the trivalent 
state  is  obligatory  for  trypanocidal activity  (27). 
The decreased GSH  levels  in Melarsenoxide-treated trypanosomes give  the 
organisms  an increased susceptibility  to heme  lysis. As shown  in Fig. 3, 
combining sublytic  concentrations  of  Melarsenoxide (0.5/zM)  and heme (10/~M) 
caused lysis  of  the organisms at a faster  rate  than that observed with 60/~M 
heine alone (data not shown).  A  more pronounced synergism was observed 
when isolated  trypanosomes were treated with sublytic  concentrations of  both 
menadione  and Melarsenoxide before treatment with heine  (Fig. 3f). This 
synergism points to the potential  usefulness of such a combined therapeutic 
regimen. 
An example of  the synergism between arsenicals  and porphyrins in vivo  is 
presented in Table III.  Both the rate  of  cure and the average survival  time of 
mice infected  with  T. b. brucei are increased  when the animals are treated  with 
regimens involving both tryparsamide and hematoporphyrin D. The minimal 
curative doses of  hematoporphyrin D and tryparsamide alone are 160 and 500 
mg/kg, respectively.  When administered  separately, 25 mg/kg of hematopor- 
phyrin D and 100 mg/kg of  tryparsamide had no effect  on survival,  whereas the 
coadministration of both drugs resulted in a twofold increase in the average 
survival time of  the mice. Unfortunately, the naphthoquinones tested  to date 
have had no effect  on survival  when administered in combination with hema- 
toporphyrin D, tryparsamide, or  both.  Nonetheless, we are  continuing to  screen 576  NEW  DRUGS  FOR AFRICAN  TRYPANOSOMIASIS 
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FIG.  3.  The effect of menadione and arsenicals on the heine lysis of T. b. brucei. Purified 
bloodstream forms (1-2  ×  107 organisms) were suspended in 1 ml of PSG 6:4/MEM 9/1 and 
maintained at 37°C.  The turbidity of the suspensions was measured at 750 nm. Additions of 
Melarsenoxide,  Melarsen,  menadione,  and heme were  made as  indicated by the arrows 
such that the final concentrations were those shown. 
TABLE  III 
The Effects of a Combined Regimen of Tryparsamide and Hematoporphyrin 
D on the Survival ofT. b. brucei-Infected Mice 
Hematopor- 
phyrin D 
Tryparsamide (mg/kg) 
0  100  200  500 
mglkg 
0  3,3,3,4,4*  4,4,4,4,4  3,5,6,7,8  C,C,C,C,C 
25  4,4,4,4,4  5,7,8,8,8  9,10,11,C,C  N.D. 
50  8,8,8,9,9  9,9,9,C,C,  9,13,15,C,C,  N.D. 
160  C,C,C,C,C,$  N.D.§  N.D.  N.D. 
* Days to death postinfection. 
$ C, cured (survived 28 days). 
§ N.D., not determined. 
naphthoquinones for in vitro effectiveness  given the magnitude of  their response 
in vitro. 
Discussion 
The presence of H202 in trypanosomes and the lack of enzymes to dispose of it 
represent  an  important  biochemical  difference  between  these  parasites  and 
their mammalian hosts. Fig.  1 shows that portion of the parasites biochemistry 
in which the production of H202 is thought to arise,  and it depicts those sites 
where we have sought to intervene to increase the concentration of intracellular 
H20~ or its homolytic cleavage products. We have previously shown that heme MESHNICK,  BLOBSTEIN,  GRADY,  AND  CERAMI  577 
in vitro and porphyrins in vivo are capable of killing the bloodstream form of T. 
b.  brucei,  presumably via their ability to initiate free radical reactions. This 
has prompted us to search for new agents with increased effectiveness in vivo. 
We have succeeded in substantially increasing the production of H202 by both 
isolated organisms and mitochondrial preparations via the addition of naph- 
thoquinones. The increased intracellular H202  concentration confers upon the 
organisms  an  increased  susceptibility  to  lysis  by  heme.  Unfortunately,  a 
naphthoquinone that  is  active in  vivo has  not been found, but we are still 
searching for such a compound. Another way in which we have increased the 
trypanocidal  activity  of  heme  in  vitro  and  in  vivo  is  by  increasing  the 
susceptibility of the organisms to radical damage. This has been accomplished 
by using arsenicals to diminish the concentration of reduced glutathione within 
the organisms. Thus, the main defense of the cells against radical damage is 
compromised. As in the case of the naphthoquinones, administering arsenicals 
in combination with heme and hematoporphyrin D resulted in a  synergistic 
effect in  vitro  and in  vivo,  respectively. We hope that eventually it will be 
possible to develop a therapeutic regimen based on the scheme outlined here 
utilizing  a  combination of agents which will:  (a)  increase the production of 
H202,  (b)  lead to  its  homolytic cleavage, and (c) render trypanosomes more 
susceptible to damage by the free radicals produced. 
Summary 
The  inability  of the  bloodstream  form  of Trypanosoma  brucei  brucei  to 
decompose hydrogen peroxide forms the basis of our attempt to develop new 
pharmacological agents to  kill these organisms.  Approximately 1-3% of the 
oxygen consumed by these parasites appears in the form of hydrogen peroxide. 
Our previous observation that free radical initiators such as heme and hemato- 
porphyrin  D  proved  to  be  trypanocidal  in  vitro  and  in  vivo,  respectively, 
prompted  this  investigation  into  the  mechanism of action  of this  class  of 
compounds to enhance their therapeutic efficacy. 
The locus of H202 production within the trypanosome was examined using 
cell-free  homogenates.  Experiments  described  herein  suggest  that  H202 is 
formed by the a-glycerol phosphate dehydrogenase in an adventitious manner, 
and that no enzymatic means of disposing of this potentially toxic compound are 
present  with  the  organisms.  Naphthoquinones were  found to  substantially 
increase the rate of both oxygen consumption and H202 production by trypano- 
somal mitochondrial preparations. Presumably, the naphthoquinones are act- 
ing as coenzyme Q analogues. The addition of sublytic concentrations of both 
naphthoquinones and heme leads to a synergistic lysis of the organisms in vitro. 
Another approach to  increasing the  susceptibility of T.  b.  brucei  to  free 
radical damage involved reduction of the intracellular concentration of gluta- 
thione.  This  was  accomplished through the  use  of trypanocidal arsenicals. 
Melarsenoxide and heme acted synergistically in  vitro,  an effect which was 
further enhanced via  addition  of a  naphthoquinone.  Moreover,  hematopor- 
phyrin D and tryparsamide were shown to have a  synergistic effect in T.  b. 
brucei- infected mice. 
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